Lentigo Maligna Melanoma
Am Fam Physician. 2000 Jun 1;61(11):3385-3386.
A 63-year-old man presented to the office for evaluation of a brown patch on his upper cheek and lower eyelid (see the accompanying photo). The patch had been present for more than 10 years and was gradually increasing in size. The patient had no visual complaints, adenopathy or other suspicious lesions. He has had a number of basal cell and squamous cell carcinomas excised over the past two decades. On physical examination, the patch demonstrated an irregular border and uneven pigmentation.
Given the patient's history and the physical appearance of the patch, which one of the following steps should be performed next to make a diagnosis?
A. Freeze with liquid nitrogen spray and recheck in three months.
B. Apply 4 percent hydroquinone cream nightly and recheck in three months.
C. Perform a 2-mm punch biopsy at the edge of the lesion.
D. Perform the largest incisional biopsy you can close without impairment of eyelid function.
E. Perform three 2-mm punch biopsies, one each at the edge of the lesion, the darkest part of the lesion and the thickest part of the lesion.
The answer is D: perform the largest incisional biopsy you can close without impairment of eyelid function. Lentigo maligna melanoma1 is an in-situ presentation of malignant melanoma. The usual presentation is on sun-exposed areas such as the face or bald scalp. The lesion typically has a very indolent course, which may span decades. While many spread superficially and remain in-situ, that is, confined to the epidermis and dermal-epidermal junction, others may become more invasive, and death from metastatic disease may occur. Older names, such as “Hutchinson's melanotic freckle,” obscure the fact that lentigo maligna melanoma is a potentially lethal condition that should be treated definitively as soon as it is identified and is not a condition to be followed clinically until it becomes obviously invasive.
Some suggest that one or more punch biopsies through “the most suspicious part” of a pigmented lesion are adequate for diagnosis. Unfortunately, one cannot always predict by visual inspection alone which part of a large lesion will be the most diagnostic or where the deepest invasion of a melanoma occurs. In the best-case scenario, melanoma will be recognized pathologically although the maximum depth of the tumor (which is the most important factor for prognosis) remains unknown, and the optimal margins for excision will be difficult to determine. In the worst-case scenario, the sample size will be too small (especially with small punches), the melanoma will be missed, and the patient and physician will be falsely reassured. The best way to biopsy a suspected melanoma is complete removal or, when not practical, obtaining the largest amount of tissue possible. Partially removing a melanoma does not make it more likely to metastasize.
Cryotherapy is often used for treatment of actinic keratoses, warts and seborrheic keratoses but is not recommended for destruction of melanocytic nevi or it may obscure an occult melanoma. Any lesion, even one presumed benign, that repeatedly recurs after proper cryotherapy should be biopsied. Topical hydroquinone may be effective therapy for melasma and, on some occasions, for treatment of post-inflammatory hyperpigmentation.
The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the policies of the Department of Defense or the U.S. Air Force.
1. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Amer Acad Dermatol. 1995;33:923–36.
The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at http://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. E-mail submissions to firstname.lastname@example.org.
Copyright © 2000 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Aug 1, 2018
Access the latest issue of American Family Physician